C-Rad
44.2 SEK -2.86%Be the first to follow this company
C-Rad is active in medical technology. The company conducts the development, manufacturing, and sales of products and solutions in advanced radiation therapy. The business is mainly aimed at clinics that offer radiation treatment, where the company in addition to its core business offers associated installation services and support. The customers are located on a global level and the head office is located in Uppsala.
Revenue
-
EBIT %
-
P/E
32.5
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
CRAD B
Daily low / high price
44.05 / 45.3
SEK
Market cap
1.49B SEK
Turnover
1.66M SEK
Volume
37K
Financial calendar
Interim report
23.10.2024
Annual report
07.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Svea Bank AB | 11.9 % | 11.9 % |
Linc AB | 7.6 % | 11.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
C-RAD AB has decided to repurchase own shares
Reminder: C-RAD Web Presentation Interim Report Q2 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools